Suchergebnisse - "Arnott, Clare"

PubPharm (151)

1

Effects of SGLT2 inhibitors on cause-specific cardiovascular death in patients with chronic kidney disease : a meta-analysis of CKD progression trials

enthalten in: Clinical journal of the American Society of Nephrology : CJASN | 2024

von Fletcher, R. | Herrington, W. | Agarwal, R. | +10

2

Secondary Analysis of the Salt Substitute and Stroke Study (SSaSS) : Effects of Potassium-Enriched Salt on Cardiac Outcomes

enthalten in: Hypertension (Dallas, Tex. : 1979) | 2024

von Yu, J. | Arnott, C. | Li, Q. | +12

CommentIn: Hypertension. 2024 May;81(5):1041-1043. - PMID 38630800

3

Prediction of new-onset heart failure in patients with type 2 diabetes derived from ALTITUDE and CANVAS

enthalten in: Diabetes, obesity & metabolism | 2024

von Said, F. | Arnott, C. | Voors, A. | +2

4

Knowledge, attitudes, and behaviors related to dietary salt intake and the acceptability of salt substitute among the Australian culturally and linguistically diverse community : An online survey

enthalten in: Journal of clinical hypertension (Greenwich, Conn.) | 2024

von Yu, J. | Houston, L. | Gianacas, C. | +4

5

Effects of iron on cardiovascular, kidney and safety outcomes in patients with chronic kidney disease: a systematic review and meta-analysis

enthalten in: bioRxiv.org | 2024

von Chan, B. | Varghese, A. | Badve, S. | +12

6

Autoantibodies to Erythropoietin Receptor and Clinical Outcomes in Patients With Type 2 Diabetes and CKD : A Post Hoc Analysis of CREDENCE Trial

enthalten in: Kidney international reports | 2024

von Koshino, A. | Neuen, B. | Oshima, M. | +11

7

Estimated Lifetime Cardiovascular, Kidney, and Mortality Benefits of Combination Treatment With SGLT2 Inhibitors, GLP-1 Receptor Agonists, and Nonsteroidal MRA Compared With Conventional Care in Patients With Type 2 Diabetes and Albuminuria

enthalten in: Circulation | 2024

von Neuen, B. | Heerspink, H. | Vart, P. | +13

8

Primary and Secondary Cardiovascular and Kidney Prevention With Canagliflozin : Insights From the CANVAS Program and CREDENCE Trial

enthalten in: Journal of the American Heart Association | 2024

von Sharma, A. | Razaghizad, A. | Joury, A. | +11

9

The Effect of Weight Loss Through Lifestyle Interventions in Patients With Heart Failure With Preserved Ejection Fraction-A Systematic Review and Meta-Analysis of Randomised Controlled Trials

enthalten in: Heart, lung & circulation | 2024

von Lee, V. | Houston, L. | Perkovic, A. | +5

10

Timing of statistical benefit of canagliflozin in patients with type 2 diabetes for cardiovascular and heart failure outcomes : Insights from the CANVAS Program and CREDENCE trial

enthalten in: Diabetes, obesity & metabolism | 2024

von Sharma, A. | Marques, P. | Neuen, B. | +9

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[16]